MacroGenics Files 8-K on Security Holder Vote Matters

Ticker: MGNX · Form: 8-K · Filed: May 22, 2025 · CIK: 1125345

Sentiment: neutral

Topics: corporate-governance, shareholder-vote

Related Tickers: MGNX

TL;DR

MGNX filed an 8-K, shareholders are voting on something important.

AI Summary

On May 21, 2025, MacroGenics, Inc. filed an 8-K report indicating a submission of matters to a vote of security holders. The company, incorporated in Delaware with its principal executive offices in Rockville, Maryland, is involved in the pharmaceutical preparations industry. Its common stock is traded on the Nasdaq Global Select Market under the ticker symbol MGNX.

Why It Matters

This filing signals that MacroGenics is engaging its shareholders on important corporate decisions, which could impact the company's strategic direction and future performance.

Risk Assessment

Risk Level: low — The filing is procedural and relates to a shareholder vote, not an immediate financial event or significant operational change.

Key Players & Entities

FAQ

What specific matters are being submitted for a vote of security holders?

The filing does not specify the exact matters to be voted on, only that matters are being submitted for a vote of security holders.

When was the earliest event reported in this 8-K filing?

The earliest event reported is dated May 21, 2025.

What is MacroGenics, Inc.'s principal executive office address?

The principal executive offices are located at 9704 Medical Center Drive, Rockville, Maryland 20850.

On which stock exchange is MacroGenics, Inc. common stock traded?

MacroGenics, Inc. common stock is traded on the Nasdaq Global Select Market.

What is the trading symbol for MacroGenics, Inc. common stock?

The trading symbol for MacroGenics, Inc. common stock is MGNX.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 22, 2025 regarding MACROGENICS INC (MGNX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing